Bionic eye clinical trial completed
CERA is pleased to join with our partners at Bionic Vision Australia (BVA) in announcing the successful completion of the first clinical trial of the bionic eye. CERA led the clinical and surgical components of the trial.
As Professor Mark Hargreaves, Chair of the BVA Board commented, the trial was “critically important to the continuation of our research efforts and the results exceeded all our expectations.”
During the two year study, the bionic eye implants were remarkably stable, with no significant movement, and were shown to be safe with no unexpected device-related serious adverse events observed. The trial also showed the device improved patient’s ability to see light and shapes.
The results of the trial have attracted front page coverage of the Herald Sun newspaper (Melbourne’s largest newspaper by circulation). You can read the article here
You can also read more about the ‘science’ behind the bionic eye, in a feature article in The Scientist magazine The feature includes an article by CERA’s Dr Lauren Ayton and the Bionics Institute’s Dr David Nayagam.